TMRW Life Sciences

TMRW Life Sciences creates FDA-cleared automated specimen management and storage platforms for frozen human sperm, eggs, and embryos. Their technology improves accuracy, reduces risks, and streamlines operations for fertility clinics, addressing a critical need in the growing fertility treatment market. The platform offers both on-site and off-site solutions.

Funding Round: Series D

Funding Amount: $28M+

Date: 24-Jul-2024

Investors: 5AM Ventures, FIOS Venture Holdings, DF Investment Partners, Transformation Capital, Life Sciences Innovation Fund, Casdin Capital, GV, Amy Schumer

Markets: Healthtech, Fertility Technology, Biotechnology, Life Science, Software

HQ: New York, New York, United States

Founded: 2017

Website: https://tmrwlifesciences.com/

LinkedIn: https://www.linkedin.com/company/tmrw-life-sciences-inc

Twitter: https://twitter.com/TMRWLifeSci

Instagram:

Facebook: https://www.facebook.com/TMRWLifeSciences

Crunchbase: https://www.crunchbase.com/organization/tmrw-life-sciences

Pitchbook: https://pitchbook.com/profiles/company/234729-10